Docetaxel and Dasatinib or Placebo in Men With Metastatic Castration-Resistant Prostate Cancer (READY): A Randomised, Double-Blind Phase 3 Trial
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(13)70479-0
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2013
Authors
Publisher
Elsevier BV